{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T00:45:36Z","timestamp":1787877936367,"version":"build-2784847793"},"reference-count":21,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"funder":[{"name":"Pfizer Oy","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Patient Experience"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>\n                    Alopecia areata (AA) is a chronic disease that significantly impacts well-being and quality of life. Despite its burden, professional support and treatment utilization remain low. This study investigated the experiences of 226 individuals in Finland with AA through an online survey. Most (82.7%) had at least one comorbid condition, most commonly atopic dermatitis (45.1%) and allergic rhinitis (43.4%). Depression and anxiety were reported by 22.1% and 23.0% of respondents, respectively. Those with \u226550% hair loss were significantly less likely to report higher overall well-being (odds ratio 0.60; 95% CI 0.38-0.96;\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2009=\u2009.03), and experienced a greater negative impact on their relationships and social situations compared to those with &lt;50% hair loss. The majority (82.7%) had not received any treatment for AA during the past year. Social media and peer support were the most common information sources. These findings highlight the need for improved patient education, and professional support. Healthcare providers should proactively offer guidance on treatment options and assess comorbidities to improve individual well-being.\n                  <\/jats:p>","DOI":"10.1177\/23743735251346633","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T03:38:11Z","timestamp":1748921891000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["The Diverse Experiences and Challenges of Individuals With Alopecia Areata: Survey Results From Finland"],"prefix":"10.1177","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3816-1809","authenticated-orcid":false,"given":"Johanna M.","family":"Mandelin","sequence":"first","affiliation":[{"name":"University of Helsinki and Helsinki University Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rehn","sequence":"additional","affiliation":[{"name":"Helsinki City Hospital, Helsinki, Finland"},{"name":"Mehil\u00e4inen, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0908-5288","authenticated-orcid":false,"given":"Mikko","family":"Kosunen","sequence":"additional","affiliation":[{"name":"Pfizer, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merja","family":"V\u00e4kev\u00e4inen","sequence":"additional","affiliation":[{"name":"Pfizer, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saara","family":"Rannanp\u00e4\u00e4","sequence":"additional","affiliation":[{"name":"Pfizer, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-020-00673-w"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.08.032"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.0002"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S376096"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16839"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-023-00805-4"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.07.013"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijwd.2017.07.001"},{"issue":"4","key":"e_1_3_4_10_2","article-title":"Comorbidities of alopecia areata in Finland between 1987 and 2016","volume":"100","author":"Laitinen I","year":"2020","unstructured":"Laitinen I, Jokelainen J, Tasanen K, Huilaja L. Comorbidities of alopecia areata in Finland between 1987 and 2016. Acta Derm Venereol. 2020;100(4):1-2. doi:https:\/\/doi.org\/10.2340\/00015555-3412","journal-title":"Acta Derm Venereol"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.06.047"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18926"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/ski2.301"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.2340\/actadv.v103.4441"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clindermatol.2023.03.006"},{"key":"e_1_3_4_16_2","unstructured":"Partonen M. Mood anxiety and seasonal symptoms (in Finnish). Finnish Institute for Health and Welfare; 2023."},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.18921"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-022-00711-3"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16360"},{"key":"e_1_3_4_20_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI31942"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3645"},{"issue":"2","key":"e_1_3_4_22_2","article-title":"Janus kinase inhibitors for alopecia areata","volume":"89","author":"King BA","year":"2023","unstructured":"King BA, Craiglow BG. Janus kinase inhibitors for alopecia areata. J Am Acad Dermatol. 2023;89(2S):S29-S32. doi:https:\/\/doi.org\/10.1016\/j.jaad.2023.05.049","journal-title":"J Am Acad Dermatol"}],"container-title":["Journal of Patient Experience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23743735251346633","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/23743735251346633","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/23743735251346633","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:37:38Z","timestamp":1777509458000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/23743735251346633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":21,"alternative-id":["10.1177\/23743735251346633"],"URL":"https:\/\/doi.org\/10.1177\/23743735251346633","relation":{},"ISSN":["2374-3735","2374-3743"],"issn-type":[{"value":"2374-3735","type":"print"},{"value":"2374-3743","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"article-number":"23743735251346633"}}